Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis
- 31 May 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 32 (2) , 149-158
- https://doi.org/10.1016/0165-5728(91)90007-t
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Interleukin‐2 levels in serum and cerebrospinal fluid of multiple sclerosis patientsAnnals of Neurology, 1988
- Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosisAnnals of Neurology, 1988
- Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.Journal of Clinical Investigation, 1987
- Selective Loss of the Suppressor-Inducer T-Cell Subset in Progressive Multiple SclerosisNew England Journal of Medicine, 1987
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- T-cell subsets in multiple sclerosis: A comparative study between cell surface antigens and functionClinical Immunology and Immunopathology, 1984
- T-cell subpopulations in blood and cerebrospinal fluid of multiple sclerosis patients: Effect of cyclophosphamideClinical Immunology and Immunopathology, 1983
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983
- Multiple SclerosisNew England Journal of Medicine, 1982